Zobrazeno 1 - 5 of 5 pro vyhledávání: '"U. Burkamp"'
1
Maintenance of Dose Intensity in Adjuvant Chemotherapy of Breast Cancer in Patients Treated Outside a Clinical Trial - Results of a Retrospective Study
Autor: G. Raab, Wolfgang Eiermann, M. Jaber, O. M. Koch, C. Jackisch, Achim Rody, L. Gleumes, S. Rösel, Hermann P.G. Schneider, U. Burkamp, C. Gropp, W. Dame
Publikováno v: Geburtshilfe und Frauenheilkunde. 63:333-341
Background: The quality of adjuvant chemotherapy is of general interest since maintenance of total dose and total dose intensity of chemotherapy delivered influences clinical outcome. Patients and Methods: This retrospective analysis evaluated 175 pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::25564af62874749180de3b381c060df3
https://doi.org/10.1055/s-2003-39246
Zobrazit plný text záznamu
2
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)
Autor: G. von Minckwitz, S. Loibl, M. Untch, H. Eidtmann, M. Rezai, P.A. Fasching, H. Tesch, H. Eggemann, I. Schrader, K. Kittel, C. Hanusch, J. Huober, C. Solbach, C. Jackisch, G. Kunz, J.U. Blohmer, M. Hauschild, T. Fehm, V. Nekljudova, B. Gerber, K. Gnauert, B. Heinrich, T. Prätz, U. Groh, H. Tanzer, C. Villena, A. Tulusan, B. Liedtke, J.-U. Blohmer, C. Mau, J. Potenberg, J. Schilling, M. Just, E. Weiss, U. Bückner, M. Wolfgarten, R. Lorenz, G. Doering, S. Feidicker, P. Krabisch, U. Deichert, D. Augustin, K. Kast, C. Nestle-Krämling, C. Höß, J. Terhaag, P. Fasching, P. Staib, B. Aktas, T. Kühn, F. Khandan, V. Möbus, E. Stickeler, G. Heinrich, H. Wagner, A. Abdallah, T. Dewitz, G. Emons, A. Belau, V. Rethwisch, T. Lantzsch, C. Thomssen, U. Mattner, A. Nugent, V. Müller, T. Noesselt, F. Holms, T. Müller, J.-U. Deuker, D. Strumberg, C. Uleer, E. Solomayer, I. Runnebaum, H. Link, O. Tomé, H.-U. Ulmer, B. Conrad, G. Feisel-Schwickardi, C. Schumacher, T. Steinmetz, I. Bauerfeind, S. Kremers, D. Langanke, U. Kullmer, A. Ober, D. Fischer, A. Kohls, W. Weikel, J. Bischoff, K. Freese, M. Schmidt, W. Wiest, M. Sütterlin, M. Dietrich, M. Grießhammer, D.-M. Burgmann, B. Rack, C. Salat, D. Sattler, J. Tio, E. von Abel, B. Christensen, U. Burkamp, C.-H. Köhne, W. Meinerz, S.-T. Graßhoff, T. Decker, F. Overkamp, I. Thalmann, A. Sallmann, T. Beck, T. Reimer, G. Bartzke, M. Deryal, M. Weigel, P. Weder, C.-C. Steffens, S. Lemster, A. Stefek, F. Ruhland, M. Hofmann, J. Schuster, W. Simon, U. Kronawitter, M. Clemens, W. Janni, K. Latos, W. Bauer, A. Roßmann, L. Bauer, D. Lampe, V. Heyl, G. Hoffmann, F. Lorenz-Salehi, J. Hackmann, R. Schlag
Background The GeparQuinto study showed that adding bevacizumab to 24 weeks of anthracycline–taxane–based neoadjuvant chemotherapy increases pathological complete response (pCR) rates overall and specifically in patients with triple-negative brea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd0d0889abbaa45ea11c291b5de85e20
https://www.ncbi.nlm.nih.gov/pubmed/25223482
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.
Autor: von Minckwitz G; Headquarter, German Breast Group, Neu-Isenburg; Department of Gynaecology and Obstetrics, University Hospital, Frankfurt. Electronic address: gunter.vonminckwitz@germanbreastgroup.de., Loibl S; Headquarter, German Breast Group, Neu-Isenburg., Untch M; Department of Gynaecology and Obstetrics, Klinikum Berlin-Buch, Berlin., Eidtmann H; Department of Gynaecology and Obstetrics, University Hospital, Kiel., Rezai M; Breast Center, Luisenkrankenhaus, Düsseldorf., Fasching PA; Department of Gynaecology and Obstetrics, University Hospital, Erlangen., Tesch H; Department of Medical Oncology, Chop GmbH, Frankfurt., Eggemann H; Department of Gynaecology and Obstetrics, University Hospital, Magdeburg., Schrader I; Department of Gynaecology and Obstetrics, Henriettenstiftung, Hannover., Kittel K; Department of Gynaecology and Obstetrics, Praxisklinik, Berlin., Hanusch C; Department of Gynaecology and Obstetrics, Rot-Kreuz-Klinikum, München., Huober J; Department of Gynaecology and Obstetrics, University Hospital, Ulm., Solbach C; Department of Gynaecology and Obstetrics, University Hospital, Frankfurt., Jackisch C; Department of Gynaecology and Obstetrics, Sana-Klinikum, Offenbach., Kunz G; Department of Gynaecology and Obstetrics, St Johannes Hospital, Dortmund., Blohmer JU; Department of Gynaecology and Obstetrics, St Gertrauden-Hospital, Berlin., Hauschild M; Department of Gynaecology and Obstetrics, Hospital, Rheinfelden., Fehm T; Department of Gynaecology and Obstetrics, University Hospital, Tübingen., Nekljudova V; Headquarter, German Breast Group, Neu-Isenburg., Gerber B; Department of Gynaecology and Obstetrics, University Hospital, Rostock, Germany., Gnauert K, Heinrich B, Prätz T, Groh U, Tanzer H, Villena C, Tulusan A, Liedtke B, Blohmer JU, Kittel K, Mau C, Potenberg J, Schilling J, Just M, Weiss E, Bückner U, Wolfgarten M, Lorenz R, Doering G, Feidicker S, Krabisch P, Deichert U, Augustin D, Kunz G, Kast K, von Minckwitz G, Nestle-Krämling C, Rezai M, Höß C, Terhaag J, Fasching P, Staib P, Aktas B, Kühn T, Khandan F, Möbus V, Solbach C, Tesch H, Stickeler E, Heinrich G, Wagner H, Abdallah A, Dewitz T, Emons G, Belau A, Rethwisch V, Lantzsch T, Thomssen C, Mattner U, Nugent A, Müller V, Noesselt T, Holms F, Müller T, Deuker JU, Schrader I, Strumberg D, Uleer C, Solomayer E, Runnebaum I, Link H, Tomé O, Ulmer HU, Conrad B, Feisel-Schwickardi G, Eidtmann H, Schumacher C, Steinmetz T, Bauerfeind I, Kremers S, Langanke D, Kullmer U, Ober A, Fischer D, Kohls A, Weikel W, Bischoff J, Freese K, Schmidt M, Wiest W, Sütterlin M, Dietrich M, Grießhammer M, Burgmann DM, Hanusch C, Rack B, Salat C, Sattler D, Tio J, von Abel E, Christensen B, Burkamp U, Köhne CH, Meinerz W, Graßhoff ST, Decker T, Overkamp F, Thalmann I, Sallmann A, Beck T, Reimer T, Bartzke G, Deryal M, Weigel M, Huober J, Weder P, Steffens CC, Lemster S, Stefek A, Ruhland F, Hofmann M, Schuster J, Simon W, Kronawitter U, Clemens M, Fehm T, Janni W, Latos K, Bauer W, Roßmann A, Bauer L, Lampe D, Heyl V, Hoffmann G, Lorenz-Salehi F, Hackmann J, Schlag R
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Dec; Vol. 25 (12), pp. 2363-2372. Date of Electronic Publication: 2014 Sep 15.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje